Researchers examine performance of Africa's expanded programme on immunization

NewsGuard 100/100 Score

In a paper published in PLoS Medicine last week, researchers from the Vaccines for Africa Initiative at the University of Cape Town's Institute of Infectious Disease and Molecular Medicine examine the performance of the Expanded Programme on Immunization (EPI) in Africa since its inception in 1974. "With the 2015 deadline for the Millennium Development Goals (MDGs) approaching, it is necessary for Africa to take stock, critically assess its position, take ownership of the regional and country-specific problems, and develop precise strategies to overcome the challenges identified," the authors write in the report, adding, "There is need for increased immunization systems strengthening, as many are plagued by weak infrastructure and shortage of skilled human resources"; "[m]ore affordable and adapted vaccines need to be made available"; and "[i]ncreased political and financial commitments from African governments are key factors for both maintaining current achievements and making additional progress for EPI in Africa" (3/19).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses